Alice S. Bexon
Executive at OncoResponse · Chief Medical Officer at Vyriad
Montclair, New Jersey, United States
Find your path to Alice
146 people in our graph share verified history with Alice — schools, employers, funds. One of them is your warm intro.
Chris BischoffunlockedAlice: together at University of Bristol (1992–1994)
×7Alice: together at sanofi-synthelabo
Alice: together at University of Bristol
Alice: together at Institut Gustave Roussy
Executive at OncoResponse
Intro paths
→
In turn, Alice can intro founders to OncoResponse's investors below.
OncoResponse's investors · 10
3B Future Health FundMonaco · $12M checks · since 2025ARCH Venture PartnersChicago · $50K – $250M checks · since 2021Bering CapitalSan Francisco · since 2023Canaan PartnersStamford · $500K – $20M checks · since 2025GreatPoint VenturesSan Francisco · $250K – $20M checksIntervestChevy Chase · since 2023Qatar Investment AuthorityDohaRiverVest Venture PartnersSt. Louis · $500K – $3M checks · since 2025Takeda VenturesCambridge · $1M – $5M checks · since 2023Yonjin Venture LLCCambridge
Chief Medical Officer at Vyriad
Co-founders at Vyriad
SJ
Stephen J. Russell, MD, PhDExecutive Officer, Director, Promoter
KP
Kah-Whye Peng, PhDExecutive Officer
SJ
Stephen J. RussellExecutive Chairman and Chief Scientific Officer, Co-founder
KP
Kah-Whye PengCo-Founder and Chief Technical Officer
Experience
- OncoResponseChief Medical Officercurrent2024 — presentHouston and Seattle
- March BiosciencesActing Chief Medical Officercurrent2023 — presentHouston, Texas, United States
- Bexon Clinical Consulting, LLCCEO and Principal Consultantcurrent2010 — presentTristate area
- VyriadChief Medical Officercurrent2016 — presentRochester, Minnesota
- eCTD SubmitClinical Leadcurrent2014 — presentTristate Area
- Sapience Therapeutics, Inc.CMO Sapience2019 — 2023New York, United States
- Limmedx LLCCEO and Commercial Lead2012 — 2016NJ
- Idera PharmaceuticalsVP of Clinical Development2007 — 2010
- RocheIML & CSL2001 — 2007
- sanofi-synthelaboMedical Director1998 — 2001
- NDDOClinical Trial Manager1997 — 1999
- Parexel International (Paris)CRA1997
- Institut Gustave RoussyResident1995 — 1997
Skills & more
Oncology37Clinical Development35Infectious Diseases13Biotechnology8Pharmaceutical Industry21Diabetes5Medical Affairs10Internal Medicine4Hospital Sales1Medicine3Allergy2Asthma
+8 more
PediatricsDrug DevelopmentClinical TrialsDrug DiscoveryMedical WritingImmunologyOphthalmologyPharmaceuticsLanguages French
From Alice's professional profile.
Frequently asked questions
- Who is Alice S. Bexon?
- Chief Medical Officer at Vyriad
- Where does Alice S. Bexon work?
- Alice S. Bexon is Executive at OncoResponse and Chief Medical Officer at Vyriad.
- Where did Alice S. Bexon go to school?
- Alice S. Bexon studied at Institut Gustave Roussy (Diploma, Oncology & chemotherapy); University of Bristol (mbchb, medicine).
Same school
Also attended University of Bristol360
Chris BischoffInvestment Team at General CatalystSaran DaviesInvestor at Moonfire VenturesThomas RubensInvestor at DN CapitalAnnabel StoddartOffice Manager and Executive Assistant at Medical Excellence CapitalMichael PatersonCo-Founder & former CTO of BeameryAlicia TaylorInvestment Director at Pembroke VCT
+ 354 more
